Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure

BACKGROUND: In our study, we have hypothesized that proviral DNA may show the history of mutations that emerged at previous failures to a Raltegravir containing regimen, in patients who are currently undetectable and candidates to simplification to a Dolutegravir containing regimen, in order to deci...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Caballero, Jose Ángel, Chueca, Natalia, Álvarez, Marta, Mérida, María Dolores, López, Josefa, Sánchez, José Antonio, Vinuesa, David, Martínez, María Ángeles, Hernández, José, García, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866296/
https://www.ncbi.nlm.nih.gov/pubmed/27177767
http://dx.doi.org/10.1186/s12879-016-1545-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866296/
https://www.ncbi.nlm.nih.gov/pubmed/27177767
http://dx.doi.org/10.1186/s12879-016-1545-8

Ejemplares similares